Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep318 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Atezolizumab induced new-onset type 1 diabetes mellitus and thyroiditis

de Carlos Joaquin , Zabalza Lucia , Garcia Torres Javier , Yoldi Jon , Esparza Nerea , Zubiria Juan

Introduction: Cancer is the result of genetic and epigenetic alterations generating uncontrolled cell growth. These molecular changes maintain an immunosuppressive microenvironment allowing tumor spread. Immune checkpoint inhibitors (ICI) are novel therapeutic strategies in cancer treatment, promoting anti-tumor response by boosting cytotoxic T lymphocytes. Despite their high effectiveness, they can trigger the activation of diverse autoimmune diseases in genetically predispos...

ea0099ep405 | Adrenal and Cardiovascular Endocrinology | ECE2024

Adrenal lesions in in patients with MUTYH syndrome

de Carlos Joaquin , Zabalza Lucia , Irigaray Ana , Rosario Aznarez Maria , Yoldi Jon , Marti Miguel , Ayarza-Marien Xabier , Anda Apinariz Emma

Introduction: MUTYH (MutY homolog Escherichia coli, homolog of MYH, hMYH) is a repair enzyme with a crucial role in the correction of DNA errors, being considered a protective factor of the cell. MUTYH mutations have been linked to MUTYH-associated polyposis syndrome (MAP), an autosomal recessive disorder characterized by multiple colorectal adenomas. Patients with MAP show a much higher lifetime risk of gastrointestinal cancers as an additional role of MUTYH, it appears to co...